CLINICAL TRIALS PROFILE FOR URISPAS
✉ Email this page to a colleague
All Clinical Trials for URISPAS
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00440739 ↗ | Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy (TURP) | Completed | Mahidol University | Phase 4 | 2005-09-01 | The purpose of this study is to determine whether etoricoxib, flavoxate, both are effective in the treatment postoperative pain after TURP. The research hypothesis: There is a difference in postoperative morphine consumption in the first 24 hours after transurethral prostatectomy between patients who received etoricoxib or flavoxate or both and placebo. |
| NCT00992238 ↗ | A Relative Bioavailability Study of 100 mg Flavoxate Hydrochloride Tablets Under Fasting Conditions | Completed | Padagis LLC | Phase 1 | 1969-12-31 | The purpose of this study is to compare the relative bioavailability of Flavoxate Hydrochloride tablets 100mg manufactured by Paddock Laboratories, Inc., with that of Urispas® tablets 100mg by SmithKline Beecham Pharmaceuticals under fasting conditions. |
| NCT00992238 ↗ | A Relative Bioavailability Study of 100 mg Flavoxate Hydrochloride Tablets Under Fasting Conditions | Completed | Paddock Laboratories, Inc. | Phase 1 | 1969-12-31 | The purpose of this study is to compare the relative bioavailability of Flavoxate Hydrochloride tablets 100mg manufactured by Paddock Laboratories, Inc., with that of Urispas® tablets 100mg by SmithKline Beecham Pharmaceuticals under fasting conditions. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for URISPAS
Condition Name
Clinical Trial Locations for URISPAS
Trials by Country
Clinical Trial Progress for URISPAS
Clinical Trial Phase
Clinical Trial Sponsors for URISPAS
Sponsor Name
